vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and GameStop Corp. (GME). Click either name above to swap in a different company.

GameStop Corp. is the larger business by last-quarter revenue ($821.0M vs $749.2M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). GameStop Corp. runs the higher net margin — 9.4% vs 3.6%, a 5.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs -4.6%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs -32.3%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

GameStop Corp. is an American video game, consumer electronics, and gaming merchandise retailer, headquartered in Grapevine, Texas. The brand is the largest video game retailer worldwide. As of February 2025, the company operated 3,203 stores including 2,325 both in the United States, 193 in Canada, 374 in Australia and 311 in Europe under the GameStop, EB Games, Micromania-Zing, ThinkGeek and Zing Pop Culture brands. The company was founded in Dallas in 1984 as Babbage's and took on its curr...

CLOV vs GME — Head-to-Head

Bigger by revenue
GME
GME
1.1× larger
GME
$821.0M
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+66.6% gap
CLOV
62.0%
-4.6%
GME
Higher net margin
GME
GME
5.7% more per $
GME
9.4%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
-32.3%
GME

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CLOV
CLOV
GME
GME
Revenue
$749.2M
$821.0M
Net Profit
$27.3M
$77.1M
Gross Margin
33.3%
Operating Margin
3.6%
5.0%
Net Margin
3.6%
9.4%
Revenue YoY
62.0%
-4.6%
Net Profit YoY
343.1%
EPS (diluted)
$0.05
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GME
GME
Q1 26
$749.2M
Q4 25
$487.7M
$821.0M
Q3 25
$496.6M
$972.2M
Q2 25
$477.6M
$732.4M
Q1 25
$462.3M
$1.3B
Q4 24
$337.0M
$860.3M
Q3 24
$331.0M
$798.3M
Q2 24
$356.3M
$881.8M
Net Profit
CLOV
CLOV
GME
GME
Q1 26
$27.3M
Q4 25
$-49.3M
$77.1M
Q3 25
$-24.4M
$168.6M
Q2 25
$-10.6M
$44.8M
Q1 25
$-1.3M
$131.4M
Q4 24
$-22.1M
$17.4M
Q3 24
$-9.2M
$14.8M
Q2 24
$7.4M
$-32.3M
Gross Margin
CLOV
CLOV
GME
GME
Q1 26
Q4 25
33.3%
Q3 25
29.1%
Q2 25
34.5%
Q1 25
28.3%
Q4 24
29.9%
Q3 24
24.5%
31.2%
Q2 24
30.3%
27.7%
Operating Margin
CLOV
CLOV
GME
GME
Q1 26
3.6%
Q4 25
-10.1%
5.0%
Q3 25
-4.9%
6.8%
Q2 25
-2.2%
-1.5%
Q1 25
-0.3%
6.2%
Q4 24
-6.4%
-3.9%
Q3 24
-2.7%
-2.8%
Q2 24
2.0%
-5.7%
Net Margin
CLOV
CLOV
GME
GME
Q1 26
3.6%
Q4 25
-10.1%
9.4%
Q3 25
-4.9%
17.3%
Q2 25
-2.2%
6.1%
Q1 25
-0.3%
10.2%
Q4 24
-6.6%
2.0%
Q3 24
-2.8%
1.9%
Q2 24
2.1%
-3.7%
EPS (diluted)
CLOV
CLOV
GME
GME
Q1 26
$0.05
Q4 25
$0.13
Q3 25
$0.31
Q2 25
$0.09
Q1 25
$0.36
Q4 24
$0.04
Q3 24
$0.04
Q2 24
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GME
GME
Cash + ST InvestmentsLiquidity on hand
$177.6M
$8.8B
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
$5.3B
Total Assets
$697.7M
$10.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GME
GME
Q1 26
$177.6M
Q4 25
$78.3M
$8.8B
Q3 25
$8.7B
Q2 25
$6.4B
Q1 25
$4.8B
Q4 24
$194.5M
$4.6B
Q3 24
$288.0M
$4.2B
Q2 24
$254.8M
$1.1B
Total Debt
CLOV
CLOV
GME
GME
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
$16.9M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
GME
GME
Q1 26
$339.4M
Q4 25
$308.7M
$5.3B
Q3 25
$340.9M
$5.2B
Q2 25
$344.2M
$5.0B
Q1 25
$336.1M
$4.9B
Q4 24
$341.1M
$4.8B
Q3 24
$342.2M
$4.4B
Q2 24
$324.9M
$1.3B
Total Assets
CLOV
CLOV
GME
GME
Q1 26
$697.7M
Q4 25
$541.0M
$10.6B
Q3 25
$559.7M
$10.3B
Q2 25
$575.0M
$7.5B
Q1 25
$583.7M
$5.9B
Q4 24
$580.7M
$6.2B
Q3 24
$653.0M
$5.5B
Q2 24
$674.2M
$2.6B
Debt / Equity
CLOV
CLOV
GME
GME
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
GME
GME
Operating Cash FlowLast quarter
$111.3M
Free Cash FlowOCF − Capex
$107.0M
FCF MarginFCF / Revenue
13.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
1.44×
TTM Free Cash FlowTrailing 4 quarters
$568.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
GME
GME
Q1 26
Q4 25
$-66.9M
$111.3M
Q3 25
$12.1M
$117.4M
Q2 25
$5.4M
$192.5M
Q1 25
$-16.3M
$162.3M
Q4 24
$34.8M
$24.6M
Q3 24
$50.0M
$68.6M
Q2 24
$44.8M
$-109.8M
Free Cash Flow
CLOV
CLOV
GME
GME
Q1 26
Q4 25
$-69.0M
$107.0M
Q3 25
$11.4M
$113.3M
Q2 25
$4.8M
$189.6M
Q1 25
$-16.5M
$158.8M
Q4 24
$33.3M
$20.0M
Q3 24
$49.6M
$65.5M
Q2 24
$44.4M
$-114.7M
FCF Margin
CLOV
CLOV
GME
GME
Q1 26
Q4 25
-14.1%
13.0%
Q3 25
2.3%
11.7%
Q2 25
1.0%
25.9%
Q1 25
-3.6%
12.4%
Q4 24
9.9%
2.3%
Q3 24
15.0%
8.2%
Q2 24
12.5%
-13.0%
Capex Intensity
CLOV
CLOV
GME
GME
Q1 26
Q4 25
0.4%
0.5%
Q3 25
0.1%
0.4%
Q2 25
0.1%
0.4%
Q1 25
0.0%
0.3%
Q4 24
0.5%
0.5%
Q3 24
0.1%
0.4%
Q2 24
0.1%
0.6%
Cash Conversion
CLOV
CLOV
GME
GME
Q1 26
Q4 25
1.44×
Q3 25
0.70×
Q2 25
4.30×
Q1 25
1.24×
Q4 24
1.41×
Q3 24
4.64×
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

GME
GME

Hardware And Accessories$367.4M45%
Collectibles$256.1M31%
Software$197.5M24%

Related Comparisons